The Vall d’Hebron Research Institute (VHIR) and the Institute for Bioengineering of Catalonia (IBEC) intensify their collaboration to face health challenges. With the last translational conferences, both institutions reinforce the alliance signed in 2012 to address, among others, infectious, neurodegenerative diseases, rare diseases, tissue regeneration, pediatric cancer or Parkinson’s.